Screener
Organon OGN Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Organon’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 8:46 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029532
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Deferred income taxes | 56 | 57 |
| Other noncurrent liabilities | 984 | 1,008 |
| Noncurrent liabilities held for sale | — | 32 |
| Total Liabilities | 12,093 | 12,115 |
| Contingencies (Note 15) | ||
| Organon & Co. Stockholders’ Equity: | ||
| Common stock, $0.01 par valueAuthorized - 500,000Issued and outstanding - 262,649 in 2026 and 260,316 in 2025 | 3 | 3 |
| Additional paid-in capital | 186 | 167 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Organon's total liabilities?
- Organon (OGN) reported total liabilities of $12.09B in Q1 2026.
- How has Organon's total liabilities changed year-over-year?
- Organon's total liabilities decreased by 4.1% year-over-year, from $12.61B to $12.09B.
- What is the long-term trend for Organon's total liabilities?
- Over 3 years (2022 to 2025), Organon's total liabilities has grown at a 0.7% compound annual growth rate (CAGR), from $11.85B to $12.12B.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Organon's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude